GSK plc Class Action: The Gross Law Firm Reminds GSK Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of April 7, 2025 – GSK
Portfolio Pulse from
The Gross Law Firm has announced a class action lawsuit against GSK (NYSE: GSK) regarding alleged false statements about Zantac's safety. The lawsuit covers the period from February 5, 2020 to August 14, 2022, with shareholders alleging that GSK misrepresented its knowledge about NDMA risks in the drug. The lead plaintiff deadline is set for April 7, 2025.
March 26, 2025 | 3:15 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
Class action lawsuit alleges GSK misled investors about Zantac's safety, potentially impacting the company's legal and financial standing.
The lawsuit alleges systematic misrepresentation about Zantac's safety, which could lead to significant legal costs, potential settlements, and reputational damage for GSK.
CONFIDENCE 90
IMPORTANCE 85
RELEVANCE 100